Drugs / PhIP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01092689 | Jan 2012 | malignant pancreatic neoplasm | University of Minnesota | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PhIP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01092689 ↗ |
| Route | Oral | “These subjects will ingest a very low dose of radiolabeled PhIP” NCT01092689 ↗ |